Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial)

Open access

Abstract

AIMS: Professional practice guidelines recommend that pacemaker recipients be followed regularly. However, the majority of scheduled ambulatory visits is unproductive and imposes a heavy burden on the health-care system. METHODS AND RESULTS: The COMPAS randomized, multicentre, non-inferiority trial examined the safety of long-term remote monitoring of pacemakers. Between December 2005 and January 2008, 538 patients were randomly assigned to remote monitoring follow-up (active group) vs. standard care (control group). The primary objective was to confirm that the proportion of patients who experienced at least one major adverse event (MAE), including all-cause death and hospitalizations for device-related or cardiovascular adverse events, was not >7% higher in the active than in the control group. MAE-free survivals and quality of life were compared in both groups. The characteristics of the study groups were similar. Over a follow-up of 18.3 months, 17.3% of patients in the active and 19.1% in the control group experienced at least one MAE (P < 0.01 for non-inferiority). Hospitalizations for atrial arrhythmias (6 vs. 18) and strokes (2 vs. 8) were fewer (P < 0.05), and the number of interim ambulatory visits was 56% lower (P < 0.001) in the active than the control group. Changes in pacemaker programming or drug regimens were made in 62% of visits in the active vs. 29% in the control group (P < 0.001). Quality of life remained unchanged in both groups. CONCLUSION: Remote monitoring was a safe alternative to conventional care and significantly lowered the number of ambulatory visits during long-term follow-up of permanently paced patients. ClinicalTrials.gov identifier: NCT00989326.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehr419

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (A) Cumulative survival free from MAE in each study group estimated by Kaplan–Meier analysis. (B) Outcomes of the test of non-inferiority among various patient subgroups.
Figure 1 (A) Cumulative survival free from MAE in each study group estimated by Kaplan–Meier analysis. (B) Outcomes of the test of non-inferiority among various patient subgroups.CC BY-NC · PubMed Central
Figure 2 Number of follow-ups per patient. The blue and orange curves indicate the number of follow-ups per patient in the control and the active groups, respectively. The shaded areas represent the 95% CI. At 18 months, the number of follow-ups was 36% lower in the active than in the control group. The slopes (▵) of the dotted line indicate the mean number of visits per year.
Figure 2 Number of follow-ups per patient. The blue and orange curves indicate the number of follow-ups per patient in the control and the active groups, respectively. The shaded areas represent the 95% CI. At 18 months, the number of follow-ups was 36% lower in the active than in the control group. The slopes (▵) of the dotted line indicate the mean number of visits per year.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 347

Metadata

Authors
Mabo, P., Victor, F., Bazin, P., Ahres, S., Babuty, D., Da Costa, A., Binet, D., & Daubert, J.-C.
Affiliations
  • Inserm (FR)
  • Saint Laurent Polyclinique (FR)
  • Centre Hospitalier de Redon (FR)
  • Centre Hospitalier Universitaire de Tours (FR)
Corresponding author
Mabo, Philippe
Venue
European Heart Journal
Published
2011-11-29
Volume
33
Issue
9
Pages
1105-1111
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2112916640
Cited by
347
References
19
Citations by year
2026: 7 · 2025: 18 · 2024: 12 · 2023: 28 · 2022: 16 · 2021: 30 · 2020: 36 · 2019: 27 · 2018: 20 · 2017: 28 · 2016: 17 · 2015: 29 · 2014: 22 · 2013: 38 · 2012: 19
FWCI
17.31
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • European Heart Journal (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
Commercializations Promotion Agency for R and D Outcomes
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
remote monitoring, cardiac pacemaker, permanent cardiac pacing, major adverse events, non-inferiority, hospitalization, atrial arrhythmias, stroke, quality of life, pacemaker programming, device safety
MeSH terms
Aged, Aged, 80 and over, Arrhythmias, Cardiac, Cardiac Pacing, Artificial, Female, Follow-Up Studies, Humans, Male, Pacemaker, Artificial, Postoperative Care, Treatment Outcome, Remote Consultation, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial). https://app.cochat.ai/papers/10.1093/eurheartj/ehr419
The paper
Mabo, P., Victor, F., Bazin, P., Ahres, S., Babuty, D., Da Costa, A., Binet, D., & Daubert, J.-C. (2012). A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial). European Heart Journal. https://doi.org/10.1093/eurheartj/ehr419

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.